UK Markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
193.79+0.08 (+0.04%)
At close: 04:00PM EDT
193.38 -0.41 (-0.21%)
After hours: 05:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3308.15
52-week low 3181.36
50-day moving average 3229.50
200-day moving average 3220.52

Share statistics

Avg vol (3-month) 3573.95k
Avg vol (10-day) 3689.54k
Shares outstanding 550.88M
Implied shares outstanding 6N/A
Float 850.28M
% held by insiders 11.04%
% held by institutions 1101.80%
Shares short (30 Jan 2023) 41.14M
Short ratio (30 Jan 2023) 42.36
Short % of float (30 Jan 2023) 42.88%
Short % of shares outstanding (30 Jan 2023) 42.23%
Shares short (prior month 29 Dec 2022) 41.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 24 Dec 2021
Most-recent quarter (mrq)23 Sept 2022


Profit margin 11.54%
Operating margin (ttm)18.23%

Management effectiveness

Return on assets (ttm)5.97%
Return on equity (ttm)17.26%

Income statement

Revenue (ttm)3.78B
Revenue per share (ttm)74.58
Quarterly revenue growth (yoy)10.40%
Gross profit (ttm)1.34B
EBITDA 982.91M
Net income avi to common (ttm)436.39M
Diluted EPS (ttm)7.20
Quarterly earnings growth (yoy)-6.70%

Balance sheet

Total cash (mrq)194.65M
Total cash per share (mrq)3.83
Total debt (mrq)3.35B
Total debt/equity (mrq)125.47
Current ratio (mrq)1.40
Book value per share (mrq)42.49

Cash flow statement

Operating cash flow (ttm)614.14M
Levered free cash flow (ttm)400.65M